Table 1 Distribution of ACE I/D genotypes among ESRD patients and controls
From: High prevalence of ACE DD genotype among north Indian end stage renal disease patients
| Â | Patient (n = 127) | Control (n = 150) |
|---|---|---|
Genotypes | Â | Â |
DD | 37(29.13%) | 10 (6.7%) |
II | 48(37.79%) | 100 (66.7%) |
ID | 42 (33.07%) | 40 (26.6%) |
Alelles | Â | Â |
I | 138 | 240 |
D | 116 | 60 |
Comparison of different allelic and genotypic states | ||
| Â | p- value | OR (95% CI limit) |
D v/s I | p = 0.0001 | 3.362 (2.3–4.8) |
DD v/s II | p = 0.025 | 3.524 (1.54–8.07) |
DD v/s ID+II | p = 0.0001 | 5.74 (3.4–8.5) |
DD+ID v/s II | p = 0.0001 | 3.826 (2.04–7.15) |